Analysts have provided a range of ratings for Colgate-Palmolive (NYSE:CL) over the past three months, with a mix of bullish, somewhat bullish, and indifferent sentiments. The average 12-month price target has increased to $96.67, up 6.34% from the previous average. Recent analyst actions include several rating upgrades and increased price targets, reflecting positive sentiment towards the company's financial performance.